We are live on !
Find out more
AlphaCentric Advisors Portfolio holdings
AUM
$113M
Turnover
27.4%
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter Est. Return
-3.08%
1 Year Est. Return
+27.37%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$5.41M
(-4.6%)
Cap. Flow
+$2.01M
Cap. Flow % of AUM
Cap. Flow %
1.79%
Top 10 Holdings %
Top 10 Hldgs %
23.44%
Holding
292
New
33
Increased
148
Reduced
40
Closed
47
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$4.34M |
| 2 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$1.59M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$1.58M |
| 4 |
Alpine Income Property Trust
PINE
|
+$1.46M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apogee Therapeutics
APGE
|
+$1.53M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.37M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
+$1.37M |
| 4 |
Howard Hughes
HHH
|
+$1.07M |
| 5 |
SmartStop Self Storage REIT
SMA
|
+$812K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.1% |
| 2 | Miscellaneous | 19.55% |
| 3 | Technology | 9.14% |
| 4 | Industrials | 8.04% |
| 5 | Real Estate | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Kymera Therapeutics
KYMR
$10.9B
| $640K | 0.57% |
5,729
+344
| +6% | +$39.4K |
2025 Q4
3 quarters
|
|
52
Nurix Therapeutics
NRIX
$1.69B
| $640K | 0.57% |
27,006
+1,161
| +4% | +$28.9K |
2025 Q4
3 quarters
|
|
53
Sanofi
SNY
$116B
| $633K | 0.56% |
15,345
+755
| +5% | +$32.8K |
2025 Q4
3 quarters
|
|
54
Travelers Companies
TRV
$82.6B
| $630K | 0.56% |
1,767
+1,276
| +260% | +$467K |
2025 Q4
3 quarters
|
|
55
MeiraGTx Holdings
MGTX
$882M
| $626K | 0.56% |
56,877
+2,408
| +4% | +$31.2K |
2025 Q4
3 quarters
|
|
56
Spyre Therapeutics
SYRE
$9.9B
| $619K | 0.55% |
6,956
+286
| +4% | +$27.5K |
2026 Q1
2 quarters
|
|
57
SoundHound AI
SOUN
$1.7B
| $602K | 0.53% |
100,000
| – | – |
2023 Q2
13 quarters
|
|
58
Kiniksa Pharmaceuticals
KNSA
$7.57B
| $596K | 0.53% |
+7,987
| New | +$588K |
2026 Q3
0 quarters
|
|
59
Natera
NTRA
$46.3B
| $592K | 0.53% |
1,432
+42
| +3% | +$13.2K |
2025 Q4
3 quarters
|
|
60
Oruka Therapeutics
ORKA
$7.15B
| $562K | 0.5% |
6,752
+221
| +3% | +$20.8K |
2024 Q4
7 quarters
|
|
61
Globe Life
GL
$12.1B
| $561K | 0.5% |
3,388
+1,498
| +79% | +$264K |
2025 Q4
3 quarters
|
|
62
Invesco S&P 500 BuyWrite ETF
PBP
$391M
| $554K | 0.49% |
23,771
+2,144
| +10% | +$49.8K |
2023 Q1
14 quarters
|
|
63
Invesco Senior Loan ETF
BKLN
$5.8B
| $550K | 0.49% |
26,926
+2,773
| +11% | +$56.8K |
2023 Q1
14 quarters
|
|
64
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.17B
| $549K | 0.49% |
5,427
+848
| +19% | +$87.4K |
2023 Q2
13 quarters
|
|
65
IonQ
IONQ
$13.4B
| $548K | 0.49% |
12,500
| – | – |
2026 Q2
1 quarter
|
|
66
State Street SPDR S&P International Dividend ETF
DWX
$524M
| $529K | 0.47% |
11,561
+1,012
| +10% | +$48K |
2023 Q1
14 quarters
|
|
67
Aeva Technologies
AEVA
$740M
| $526K | 0.47% |
37,500
-12,500
| -25% | -$226K |
2025 Q4
3 quarters
|
|
68
Vanguard High Dividend Yield ETF
VYM
$83.9B
| $525K | 0.47% |
3,380
+274
| +9% | +$44.4K |
2023 Q2
13 quarters
|
|
69
Marathon Petroleum
MPC
$113B
| $522K | 0.46% |
1,320
+529
| +67% | +$183K |
2026 Q1
2 quarters
|
|
70
Palladyne AI
PDYN
$159M
| $516K | 0.46% |
100,000
| – | – |
2025 Q4
3 quarters
|
|
71
Agios Pharmaceuticals
AGIO
$1.89B
| $490K | 0.44% |
14,731
+558
| +4% | +$19.5K |
2024 Q4
7 quarters
|
|
72
Amprius Technologies
AMPX
$1.16B
| $484K | 0.43% |
50,000
| – | – |
2025 Q4
3 quarters
|
|
|
OPI
73
Office Properties Income Trust
OPI
$335M
| $478K | 0.42% |
+30,000
| New | +$532K |
2026 Q3
0 quarters
|
|
74
Abivax
ABVX
$7.67B
| $476K | 0.42% |
4,811
-330
| -6% | -$39.8K |
2026 Q1
2 quarters
|
|
75
Richtech Robotics
RR
$170M
| $474K | 0.42% |
300,000
| – | – |
2025 Q4
3 quarters
|
|
Similar funds
TWS
AlphaCentric Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, AlphaCentric Advisors held 292 positions worth $113M, down 4.6% from $118M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AlphaCentric Advisors's Q3 2026 filing shows 33 new, 148 increased, 40 reduced and 47 closed positions. Its largest new stake was Alpine Income Property Trust: 75,000 shares worth $1.3M. The largest sale was Apogee Therapeutics, an estimated $1.53M.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 44% a quarter earlier, followed by Miscellaneous and Technology.
- AlphaCentric Advisors's largest Q3 2026 buy was Alpine Income Property Trust: 75,000 shares worth $1.3M.
- AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q3 2026, an estimated $4.34M increase.
- AlphaCentric Advisors's biggest Q3 2026 reduction was Graphic Packaging, cutting an estimated $428K.
- AlphaCentric Advisors fully exited Apogee Therapeutics in Q3 2026, selling an estimated $1.53M.
- AlphaCentric Advisors's ten largest holdings make up 23% of its $113M portfolio in Q3 2026.
- AlphaCentric Advisors opened 33 new positions and closed 47 in Q3 2026.
- AlphaCentric Advisors's portfolio value fell 4.6% quarter-over-quarter to $113M.
Based on AlphaCentric Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.